Expression of p-JAK2 predicts clinical outcome and is a potential molecular target of acute myelogenous leukemia
10.1002/ijc.25910
Saved in:
Main Authors: | Ikezoe, T., Kojima, S., Furihata, M., Yang, J., Nishioka, C., Takeuchi, A., Isaka, M., Koeffler, H.P., Yokoyama, A. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
2016
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/126809 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemia
by: Hart, S., et al.
Published: (2014) -
ROLE OF NOTCH AND JAK/STAT SIGNALING PATHWAYS IN ACUTE MEGAKARYOBLASTIC LEUKEMIA
by: KELLY ONG OOI KEE
Published: (2015) -
IDENTIFICATION AND CHARACTERIZATION OF NOVEL LONG NON-CODING RNAs IN ACUTE MYELOID LEUKEMIA
by: SRISHTI MISHRA
Published: (2023) -
Anti-myeloma effects of icariin are mediated through the attenuation of JAK/STAT3-dependent signaling cascade
by: Jung Y.Y., et al.
Published: (2019) -
Leptin as a neuroprotective agent
by: Tang, B.L.
Published: (2011)